NH Sen. Urges FDA To Monitor Abuse Risks Of Zohydro
A U.S. Senator from New Hampshire on Friday asked the U.S. Food and Drug Administration to implement a post-approval surveillance program for the powerful painkiller Zohydro ER, saying the agency's approval...To view the full article, register now.
Already a subscriber? Click here to view full article